Browsed by
Tag: Alzheimer Society Research Program

Research Video Series: Introducing Iva Brunec

Research Video Series: Introducing Iva Brunec

Iva Brunec is investigating how memories about the duration and order of events are created in healthy brains, and how this ability changes in those at risk for dementia. Is the ability to encode and recall information about time one of the first functions to break down with Alzheimer’s disease? Does it affect other aspects of memory as a result? This research aims to provide evidence of a sensitive indicator before a diagnosis of dementia even occurs. Investigating these disorders…

Read More Read More

Research Video Series: Introducing Hadir AlQot

Research Video Series: Introducing Hadir AlQot

Hadir AlQot aims to further our knowledge and understanding of the complex mechanisms underlying Alzheimer’s disease. Specifically, she aims to investigate a novel aspect of the cholinergic system and its vulnerability in Alzheimer’s disease in relation to key pathological features and cognitive decline. Hadir AlQot is doctoral student at the University of Western Ontario. It is my hope that this research will help unravel potential novel therapeutic targets for Alzheimer’s disease and other dementias. -Hadir AlQot Hadir AlQot Biomedical Doctoral…

Read More Read More

Research Video Series: Introducing Dr. Lisa M. Munter

Research Video Series: Introducing Dr. Lisa M. Munter

Dr. Lisa M. Munter will be investigating a novel aspect of the cholesterol metabolism with respect to Alzheimer’s disease. Her goal is to understand how dietary cholesterol affects generation of harmful amyloid peptides. She hopes to reveal whether certain lipoprotein particles of the blood may trigger amyloid generation in the brain. Dr. Munter is a researcher and professor at McGill University and the recipient of an ASRP biomedical grant. A long and prosperous life should end with human dignity. -Dr….

Read More Read More

Research Video Series: Introducing Marco Prado

Research Video Series: Introducing Marco Prado

Dr. Marco Prado’s research aims to address the mechanisms by which deficient cholinergic circuits contribute to dementia. He is an Alzheimer Society Research Program Biomedical Research Grant recipient and a professor at the University of Western Ontario. Let’s make sure that aging does not mean losing one’s identity. -Dr. Marco Prado Dr. Marco Prado Biomedical Grant Recipient in Alzheimer’s disease and dementia – $149,128 Project: Mechanisms of anti-cholinergic activity mediated dementia and Alzheimer’s pathology Read about more of our grants…

Read More Read More

Research Video Series: Introducing Laura Hamilton

Research Video Series: Introducing Laura Hamilton

Dr. Laura Hamilton is testing the efficacy of a new therapeutic target (stearoyl CoA desaturase (SCD)-1) to improve learning and memory deficits in Alzheimer’s disease using a mouse model. Laura is a postdoctoral fellow at the University of Montréal and is this year’s Alzheimer Society Research Program Spark Award Recipient. The potential to contribute to a better quality of life for millions of people motivates me every day. -Dr. Laura Hamilton Dr. Laura Hamilton Spark Postdoctoral Fellowship in Alzheimer’s Disease…

Read More Read More

Research Video Series: Introducing Stephanie Chamberlain

Research Video Series: Introducing Stephanie Chamberlain

Trained as a personal support worker in long-term care, Stephanie Chamberlain is currently pursuing her PhD at the University of Alberta. There, she is assessing the impact of court-appointed public guardianship on the health and care needs of long-term care residents. Stephanie is the Alzheimer Society Research Program’s first Revera Scholar. It is essential that we improve quality of life and quality of care to those with Alzheimer’s disease and dementia because how we treat a life that has been…

Read More Read More

Research Video Series: Introducing Dr. Rahel Rabi

Research Video Series: Introducing Dr. Rahel Rabi

At the University of Toronto, Rahel Rabi’s research focuses on diagnosis and detection, where she is working hard to identify the cognitive biomarkers of mild cognitive impairment (MCI). In this video, Rahel describes her research funded by the Alzheimer Society Research Program in her own words. Scientists have made remarkable strides in understanding Alzheimer’s disease, and with recent advances in research involving novel techniques, we can work towards finding a cure. -Rahel Rabi Rahel Rabi Rawlinson Post-Doctoral Fellowship in Alzheimer’s…

Read More Read More

What this week’s Nobel Prize in Medicine announcement means for dementia research

What this week’s Nobel Prize in Medicine announcement means for dementia research

This year’s Nobel Prize in Medicine was awarded to Japanese biologist Yoshinori Ohsumi for his discoveries on how cells eat themselves. That’s right – Ohsumi conducted experiments in the 1990s on how cells break down and recycle their components, literally eating themselves to remove damaged content and provide building blocks for cell regeneration. This process is called “autophagy”, a term that was actually coined in 1963 by Belgian scientist Christian de Duve, who also received a Nobel Prize for his work in this area….

Read More Read More

Changing the way dementia research is done in Canada

Changing the way dementia research is done in Canada

Research is usually researcher-driven. We want to help change that. What do we mean? Researchers usually decide what work is important enough to be funded and then good enough to be published. But are researchers aware of the issues that matter most to those who can actually benefit from their work? Not always. That’s why we’ve created the Canadian Dementia Priority Setting Partnership, a study that will bring the voices of Canadians affected by dementia into the conversation about research.

Introducing the 2016 Alzheimer Society Research Program (ASRP) Community Representatives

Introducing the 2016 Alzheimer Society Research Program (ASRP) Community Representatives

This year the Alzheimer Society celebrates 28 years of funding research through the Alzheimer Society Research Program (ASRP). The peer review panel meetings were held in February 2016 in Toronto, Ontario, and included the role of Community Representatives. Community Representatives are members of the general public who are not currently involved with research who are given the opportunity to comment on the intent, purpose and on the clarity of the language used within the lay summaries of research applications that are received by the Society. Their involvement in peer review serves as a mechanism for public accountability by providing feedback on the ASRP peer review process.